TY - JOUR
T1 - Redefining phenotypes associated with mitochondrial DNA single deletion
AU - Mancuso, Michelangelo
AU - Orsucci, Daniele
AU - Angelini, Corrado
AU - Bertini, Enrico
AU - Carelli, Valerio
AU - Comi, Giacomo Pietro
AU - Donati, Maria Alice
AU - Federico, Antonio
AU - Minetti, Carlo
AU - Moggio, Maurizio
AU - Mongini, Tiziana
AU - Santorelli, Filippo Maria
AU - Servidei, Serenella
AU - Tonin, Paola
AU - Toscano, Antonio
AU - Bruno, Claudio
AU - Bello, Luca
AU - Caldarazzo Ienco, Elena
AU - Cardaioli, Elena
AU - Catteruccia, Michela
AU - Da Pozzo, Paola
AU - Filosto, Massimiliano
AU - Lamperti, Costanza
AU - Moroni, Isabella
AU - Musumeci, Olimpia
AU - Pegoraro, Elena
AU - Ronchi, Dario
AU - Sauchelli, Donato
AU - Scarpelli, Mauro
AU - Sciacco, Monica
AU - Valentino, Maria Lucia
AU - Vercelli, Liliana
AU - Zeviani, Massimo
AU - Siciliano, Gabriele
PY - 2015
Y1 - 2015
N2 - Progressive external ophthalmoplegia (PEO), Kearns-Sayre syndrome (KSS) and Pearson syndrome are the three sporadic clinical syndromes classically associated with single large-scale deletions of mitochondrial DNA (mtDNA). PEO plus is a term frequently utilized in the clinical setting to identify patients with PEO and some degree of multisystem involvement, but a precise definition is not available. The purpose of the present study is to better define the clinical phenotypes associated with a single mtDNA deletion, by a retrospective study on a large cohort of 228 patients from the database of the "Nation-wide Italian Collaborative Network of Mitochondrial Diseases". In our database, single deletions account for about a third of all patients with mtDNA-related disease, more than previously recognized. We elaborated new criteria for the definition of PEO and "KSS spectrum" (a category of which classic KSS represents the most severe extreme). The criteria for "KSS spectrum" include the resulting multisystem clinical features associated with the KSS features, and which therefore can predict their presence or subsequent development. With the new criteria, we were able to classify nearly all our single-deletion patients: 64.5% PEO, 31.6% KSS spectrum (including classic KSS 6.6%) and 2.6% Pearson syndrome. The deletion length was greater in KSS spectrum than in PEO, whereas heteroplasmy was inversely related with age at onset. We believe that the new phenotype definitions implemented here may contribute to a more homogeneous patient categorization, which will be useful in future cohort studies of natural history and clinical trials.
AB - Progressive external ophthalmoplegia (PEO), Kearns-Sayre syndrome (KSS) and Pearson syndrome are the three sporadic clinical syndromes classically associated with single large-scale deletions of mitochondrial DNA (mtDNA). PEO plus is a term frequently utilized in the clinical setting to identify patients with PEO and some degree of multisystem involvement, but a precise definition is not available. The purpose of the present study is to better define the clinical phenotypes associated with a single mtDNA deletion, by a retrospective study on a large cohort of 228 patients from the database of the "Nation-wide Italian Collaborative Network of Mitochondrial Diseases". In our database, single deletions account for about a third of all patients with mtDNA-related disease, more than previously recognized. We elaborated new criteria for the definition of PEO and "KSS spectrum" (a category of which classic KSS represents the most severe extreme). The criteria for "KSS spectrum" include the resulting multisystem clinical features associated with the KSS features, and which therefore can predict their presence or subsequent development. With the new criteria, we were able to classify nearly all our single-deletion patients: 64.5% PEO, 31.6% KSS spectrum (including classic KSS 6.6%) and 2.6% Pearson syndrome. The deletion length was greater in KSS spectrum than in PEO, whereas heteroplasmy was inversely related with age at onset. We believe that the new phenotype definitions implemented here may contribute to a more homogeneous patient categorization, which will be useful in future cohort studies of natural history and clinical trials.
KW - CPEO
KW - KSS
KW - Mitochondrial disorders
KW - Pearson syndrome
KW - Single deletion
KW - mtDNA
KW - CPEO
KW - KSS
KW - Mitochondrial disorders
KW - Pearson syndrome
KW - Single deletion
KW - mtDNA
UR - http://hdl.handle.net/10807/71886
U2 - 10.1007/s00415-015-7710-y
DO - 10.1007/s00415-015-7710-y
M3 - Article
SN - 0340-5354
VL - 262
SP - 1301
EP - 1309
JO - Journal of Neurology
JF - Journal of Neurology
ER -